Deep6.ai

Through groundbreaking technology, we are revolutionizing clinical trial recruitment at Deep 6 AI. Founded in 2016, our mission is to bring life-saving treatments to patients faster by leveraging the power of artificial intelligence. We specialize in developing advanced AI and natural language processing (NLP) technologies to mine and interpret vast amounts of structured and unstructured patient data from electronic medical records (EMRs). This enables us to precisely match eligible patients to clinical trials in minutes, rather than the months it traditionally takes. Our innovative approach eliminates extensive manual data validation, de-risking and accelerating the entire clinical trial process. The Deep 6 AI platform creates dynamic, holistic patient views, generating new clinical insights and leveraging wider clinical context for matches. We are committed to transforming clinical trials from a bottleneck into an accelerator for medical innovation.

The Deep 6 Precision Research Ecosystem connects a wide range of stakeholders, including researchers, physicians, sponsors, and Contract Research Organizations (CROs), fostering collaboration and advancing research at an unprecedented pace. Our AI-powered software is implemented enterprise-wide in healthcare organizations, allowing access to a broader patient population beyond a single principal investigator's panel. This comprehensive reach, combined with our ability to analyze both structured data like ICD-10 codes and unstructured data such as physician notes, pathology reports, and lab results, ensures more accurate and efficient patient identification. Deep 6 AI's technology supports various aspects of the clinical trial lifecycle, from trial design and site selection to patient recruitment and real-world evidence generation. By partnering with leading academic medical centers, NCI-Designated Cancer Centers, and NCI Community Oncology Research Programs, we are building a robust network dedicated to accelerating the delivery of novel therapies. In March 2025, Deep 6 AI was acquired by Tempus, a move that further enhances our capabilities and reach in advancing precision medicine.